Navigation Links
Discovery that PARP protein exists in all breast tumors will help target chemo and predict response
Date:3/26/2010

e or anti-HER2 therapy available for this aggressive form of breast cancer."

However, it remains to be seen whether immunohistochemical detection (the process of localising antigens in tissue cells) of PARP is the best method of predicting PARP inhibitor efficacy, the scientists say. "We need more prospective trials to be sure that there is no better way of making sure that the right people are getting the right therapy," says Professor von Minckwitz. "However, it would be fair to say that we believe that we may be on the verge of a major change in the way breast cancer is treated."


'/>"/>

Contact: Mary Rice
mary@mrcommunication.org
ECCO-the European CanCer Organisation
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Chance discovery leads to plant breeding breakthrough
2. A-maize-ing discovery could lead to higher corn yields for food, feed and fuel
3. African bird discovery proves there is something new under the sun
4. Discovery in legumes could reduce fertilizer use, aid environment: Stanford researchers
5. Startup joins UCLA tech incubator to develop technologies for drug discovery, screening
6. An electrifying discovery: New material to harvest electricity from body movements
7. New gene discovery could help to prevent blindness
8. First discovery of the female sex hormone progesterone in a plant
9. Enlisting a drug discovery technique in the battle against global warming
10. TGen becomes center of excellence for Horizon Discoverys GENESIS and X-MAN technology
11. Gene function discovery: Guilt by association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... , Dec. 18, 2014 Research and ... the addition of the "iPhone 5S Fingerprint ... Report" report to their offering. ... the acquisition of AuthenTec in July 2012, Apple ... 5S. It is currently the only device of ...
(Date:12/19/2014)... 18, 2014   LaunchKey , the first decentralized ... and Internet of Things era, today announced the close ... round was led by Metamorphic Ventures with participation from ... VegasTechFund, and others.  LaunchKey has raised $4 million to ... its team and bring LaunchKey to market in 2015. ...
(Date:12/17/2014)... , Dec. 15, 2014  HITLAB SM ... Clinical Practices (GCP) audit to confirm its adherence ... regulations. This accomplishment enables HITLAB to conduct regulated ... the highest principles for patient safety and research ... global healthcare access, quality, and delivery with innovative ...
Breaking Biology News(10 mins):iPhone 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 & Sapphire - Technology Report 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2
... 1st issue of G&D, Drs. Yong Sun Lee and Anindya ... in vitro. , "Overexpression of HMGA2 is an important ... Dutta. “It is very exciting to realize that microRNAs have ... so may have a role in the causation and perhaps ...
... blockbuster "Finding Nemo" when a school of fish makes a rapid ... other intricate designs. While the detailed shapes might be a bit ... how does a school of fish or a flock of birds ... reorganize as a unit, without knowing what the entire group is ...
... K. Long, MD, an endocrinology research fellow at the ... California, San Francisco, was one of only three scientists ... the National Space Biomedical Research Institute (NSBRI). , Long's ... possible methods of treating or preventing bone loss resulting ...
Cached Biology News:University of Alberta researchers unravel intricate animal patterns 2University of Alberta researchers unravel intricate animal patterns 3Researcher to study astronaut bone loss for space biology agency 2Researcher to study astronaut bone loss for space biology agency 3
(Date:12/24/2014)... , Dec. 23, 2014 Sigma-Aldrich ... that the waiting period under the Hart-Scott-Rodino Antitrust ... acquisition expired on December 22, 2014, thereby completing ... requirement for the acquisition of the Company by ... antitrust clearance satisfies another condition to closing the ...
(Date:12/22/2014)... 22, 2014 /PRNewswire/ - RepliCel Life Sciences Inc. (OTCQB: ... focused on the development of autologous cell therapies, announced ... University of Calgary in conjunction with co-authors from Kyoto ... validates the company,s ongoing clinical research using dermal sheath ... baldness. The paper entitled " Hair Follicle ...
(Date:12/22/2014)... ITRA Global, one of the largest organizations ... estate, has further expanded its global reach with the ... Western Australia, reports Mylinda Vick, CCIM, Chairman of the ... / ACORPP (Australian Corporate Property and Projects) , is ... services to a wide range of clients in the ...
(Date:12/19/2014)... , Dec. 19, 2014 Naurex Inc., ... novel drugs for diseases of the central nervous system, ... and chief executive officer, will present at the 33 ... presentation will take place at 3:00 p.m. PST on ... in San Francisco, Calif. ...
Breaking Biology Technology:Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 2Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 2Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 4Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 5ITRA Global Continues International Expansion in Perth and Brisbane, Australia 2Naurex to Present at 33rd Annual J.P. Morgan Healthcare Conference 2
... ... distribution partner for the Taiwanese market. Uni-Onward,s recent focus on USP/NF grade chemicals is ... lab chemicals distributor in Taiwan and has built an outstanding reputation since its establishment ... ...
... Researchers from Rensselaer Polytechnic Institute have developed a ... strength of infrared imaging and could lead to a ... By leveraging the unique properties of nanoscale gold ... of the device, the researchers have doubled the detectivity ...
... OriGene Technologies, Inc. with the support of Wuxi Biopharmaceutical R&D ... and most sophisticated monoclonal antibody production centers in the world in Wuxi, ... have over one thousand employees with the capacity to produce over 20,000 ... , ...
Cached Biology Technology:Spectrum Announces Uni-Onward as its Taiwanese Distributor 2Nanotech discovery at Rensselaer could lead to breakthrough in infrared satellite imaging technology 2Nanotech discovery at Rensselaer could lead to breakthrough in infrared satellite imaging technology 3OriGene Technologies, Inc. to Build the World's Largest TrueMAB(TM) Monoclonal Antibody Facility in Wuxi, China 2
... Gelzyme is an agarose-digesting enzyme ... cleaves simple carbohydrate bonds in agarose ... longer gel. The remaining carbohydrate molecules ... manipulation. DNA isolated with Gelzyme enzyme ...
RAT ANTI MOUSE METALLOPHILIC MACROPHAGES...
S. O'Hare & C.K. Atterwill • In vitro toxicity techniques for regular lab use. Ex vivo techniques are also covered with the aim of reducing and refining the use of animals in the future....
Form: Ready to use Applications: ELISA...
Biology Products: